NASDAQ$NKTR
Nektar Therapeutics · Q1 2020 earnings
Q1 2020 earnings · · Investor relations
Briefing
Reported financial results for the first quarter ended March 31, 2020.
Nektar Therapeutics reported Q1 2020 financial results, with revenue increasing to $50.6 million compared to $28.2 million in Q1 2019, primarily due to a milestone payment from Bristol-Myers Squibb. The net loss for the quarter was $138.7 million, or $0.78 per share, compared to a net loss of $119.6 million, or $0.69 per share, in Q1 2019. The company's cash and investments in marketable securities were approximately $1.5 billion as of March 31, 2020.
- Revenue increased to $50.6 million, up from $28.2 million in the first quarter of 2019.
- A $25.0 million milestone payment from Bristol-Myers Squibb contributed to the revenue increase.
- Net loss was $138.7 million, or $0.78 per share, compared to a net loss of $119.6 million, or $0.69 per share, in the first quarter of 2019.
- Cash and investments in marketable securities were approximately $1.5 billion as of March 31, 2020.
Headline financials
Revenue & EPS history
Nektar · Revenue · Quarterly
$50.6M
Forward guidance
Nektar expects enrollment and study starts managed by partners will likely be delayed from three to six months due to COVID-19 but the company's strong financial position provides a solid foundation.
Headwinds
- Enrollment and study starts managed by partners will likely be delayed from three to six months.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2020
+0.7%
Avg return
Earnings day
+1.5%
Avg return
5 days after
-3.8%
Avg return
30 days after
50%
32 / 64 earnings
Positive
+24.8%
Q3 2017
Best reaction
-27.4%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | -7.9% | -32.6% | |
| Q4 2025 | +4.0% | +4.0% | +10.1% | |
| Q3 2025 | +1.9% | +4.6% | +3.2% | |
| Q1 2025 | -4.1% | +16.1% | +8.1% | |
| Q4 2024 | -0.6% | +7.3% | -24.4% | |
| Q3 2024 | +0.7% | -5.8% | -26.6% | |
| Q2 2024 | -5.9% | -2.5% | -5.1% | |
| Q1 2024 | +7.3% | +7.9% | -23.2% | |
| Q4 2023 | +13.3% | +16.7% | +33.3% | |
| Q3 2023 | -5.6% | -15.1% | -3.8% | |
| Q2 2023 | -10.8% | -8.8% | -42.2% | |
| Q1 2023 | -2.6% | -5.2% | -22.1% | |
| Q4 2022 | +8.6% | +12.9% | -54.0% | |
| Q3 2022 | +3.6% | +4.1% | -16.2% | |
| Q2 2022 | +9.2% | +5.4% | -10.3% | |
| Q1 2022 | -6.7% | -17.0% | -22.1% | |
| Q4 2021 | +10.0% | +5.2% | -44.2% | |
| Q3 2021 | -21.0% | -18.8% | -36.4% | |
| Q2 2021 | +1.0% | -4.0% | +1.6% | |
| Q1 2021 | +7.6% | +3.3% | -8.3% | |
| Q4 2020 | -0.4% | +4.3% | -12.2% | |
| Q3 2020 | +2.7% | -0.8% | +2.5% | |
| Q2 2020 | +0.5% | -6.2% | -13.0% | |
| Q1 2020 | +6.3% | +11.3% | +14.0% | |
| Q4 2019 | -2.8% | -9.2% | -19.5% | |
| Q3 2019 | +0.9% | +13.2% | +10.3% | |
| Q2 2019 | -27.4% | -34.5% | -40.9% | |
| Q1 2019 | +10.5% | +1.7% | +2.9% | |
| Q4 2018 | -7.1% | -6.4% | -18.1% | |
| Q3 2018 | -2.1% | +2.5% | +2.5% | |
| Q2 2018 | +8.7% | +8.6% | +19.0% | |
| Q1 2018 | +2.1% | +7.2% | -30.4% | |
| Q4 2017 | +18.8% | +13.3% | +22.8% | |
| Q3 2017 | +24.8% | +33.9% | +125.8% | |
| Q2 2017 | -7.8% | -9.8% | +11.0% | |
| Q1 2017 | +5.8% | +9.9% | +4.1% | |
| Q4 2016 | +13.1% | +9.9% | +79.4% | |
| Q3 2016 | -1.1% | +5.1% | -0.6% | |
| Q2 2016 | +1.6% | +0.5% | +7.4% | |
| Q1 2016 | -12.3% | — | — | |
| Q4 2015 | -0.2% | — | — | |
| Q3 2015 | +4.3% | — | — | |
| Q2 2015 | -5.6% | — | — | |
| Q1 2015 | +13.3% | — | — | |
| Q4 2014 | -2.7% | — | — | |
| Q3 2014 | -1.8% | — | — | |
| Q2 2014 | +7.4% | — | — | |
| Q1 2014 | -2.9% | — | — | |
| Q4 2013 | -2.5% | — | — | |
| Q3 2013 | +15.8% | — | — | |
| Q2 2013 | +11.9% | — | — | |
| Q1 2013 | -4.1% | — | — | |
| Q4 2012 | +1.6% | — | — | |
| Q3 2012 | -14.1% | — | — | |
| Q2 2012 | +0.6% | — | — | |
| Q1 2012 | -1.0% | — | — | |
| Q4 2011 | +9.5% | — | — | |
| Q3 2011 | -1.5% | — | — | |
| Q2 2011 | -5.4% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q4 2010 | -4.9% | — | — | |
| Q3 2010 | -4.8% | — | — | |
| Q2 2010 | -2.2% | — | — | |
| Q1 2010 | -10.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro